Chromatography serves as a laboratory technique for the separation of mixtures and finds extensive application in diverse industries, including life sciences, pharmaceuticals, agriculture, and biotechnology, owing to its precision and efficiency.
The outbreak of the coronavirus has positively impacted the global chromatography systems market, particularly in drug development processes. The universal acceptance of chromatography techniques in drug manufacturing, especially during the pandemic, has led to an increased demand. Additionally, growing awareness of chromatography’s importance in laboratories and the pharmaceutical industry is anticipated to drive market growth in the forecast period.
The demand for chromatography systems is poised to rise significantly due to increased research activities related to the influence of coronavirus on the body and the detection of cancer cells. Ongoing technological advancements in chromatography systems are expected to create substantial opportunities for market growth in the post-pandemic era. Chromatography systems have evolved into powerful tools, demonstrating adaptability in achieving efficient separation, identification, and purification of compounds in mixtures across various industries such as chemical, pharmaceutical, agriculture, food & beverage, petroleum, drug testing, clinical testing, and more.
Chromatography is a non-destructive biophysical process used for the separation, identification, and purification of mixtures. This process involves a series of procedures leveraging different characteristics to constructively separate materials based on factors like size, charge, binding affinities, and other properties.
The impact of COVID-19 on the chromatography systems market has been unique, as it experienced a substantial surge in revenue despite the challenges faced by other industries. The stringent lockdowns globally disrupted various sectors, but the chromatography systems market saw growth due to increased use in drug development and approval processes related to the pandemic.
Research Dive’s findings indicate a real-time growth of approximately $10,952 million in the global chromatography market post-pandemic, compared to an estimated pre-pandemic market size of approximately $10,794 million. The increased application of chromatographic techniques in drug development, driven by regulatory requirements like current good manufacturing practice (cGMP), has contributed to this significant market surge.
Chromatography systems are widely employed in hospitals, laboratories, forensic labs, and pharmaceutical production sites, supporting numerous research and development activities, complex mixture separations, and the identification of cancer cells. Future prospects for the market remain promising, with ongoing technological advancements expected to enhance speed, efficiency, and purity in chromatography processes. The increasing investment in effective chromatography systems by hospitals, clinics, and laboratories worldwide is anticipated to create substantial growth opportunities in the years to come.
